COMMUNIQUÉS West-GlobeNewswire

Skin health startup Derm-Biome Pharmaceuticals, Inc. to receive funding from the Government of Canada
09/07/2019
VANCOUVER, British Columbia, July 09, 2019 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a private Vancouver based start-up biopharmaceutical company focused on skin health, is excited to announce that it will [...]
BioDelivery Sciences Announces Further Improved Insurance Coverage for BELBUCA®
09/07/2019
Regional Commercial Plans Improved Access for More Than 6 Million Lives During 2Q More Than 90% of Commercial Lives Now Have Access to BELBUCA in the U.S. RALEIGH, N.C., July 09, 2019 (GLOBE NEWSWIRE) -- BioDelivery [...]
Medical Research Council Funds Phase 2 Multi-Center Study of XBiotech’s Bermekimab in Advanced Cancer Patients
09/07/2019
Medical Research Council (MRC) Grants Funding for Bermekimab as Part of its Support for “Outstanding Clinical Programs in the United Kingdom” AUSTIN, Texas, July 09, 2019 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT) [...]
Lutronic Vision to Present R:GEN™ Efficacy Data at 19th EURETINA Congress
09/07/2019
- Presentation to highlight results of R:GEN™ laser treatment from a clinical trial in patients with Central Serous Chorioretinopathy - BILLERICA, Mass., July 09, 2019 (GLOBE NEWSWIRE) -- Lutronic Vision (“Lutronic” or [...]
NICE Issues Draft Guidance on the Use of gammaCore for Cluster Headache
09/07/2019
The National Institute for Health and Care Excellence (NICE) draft guidance recommends the use of gammaCore for cluster headache in the National Health Service (NHS) LONDON and BASKING RIDGE, N.J., July 09, 2019 (GLOBE [...]
CytomX Therapeutics Announces Second Target Selection and Program Initiation with AbbVie Under Ongoing, Multi-Program Strategic Oncology Collaboration
09/07/2019
-Triggers $10 Million Milestone Payment to CytomX- SOUTH SAN FRANCISCO, Calif., July 09, 2019 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company [...]
GBT Announces New Employment Inducement Grants
09/07/2019
SOUTH SAN FRANCISCO, Calif., July 09, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that on July 1, 2019, the compensation committee of GBT’s board of directors granted 13 [...]
Immutep Raises A$10 Million Via Private Placement and Underwritten Entitlement Offer
09/07/2019
NEW YORK, July 09, 2019 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (" Immutep ” or “ Company ”), an Australian biotechnology company developing novel immunotherapy treatments for cancer and autoimmune [...]
Inovalon Reaches Milestone and Achieves Integration With Epic
09/07/2019
myABILITY® Platform Customers Using Epic Can Now Benefit From New Integration BOWIE, Md., July 09, 2019 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven [...]
ProMIS Neurosciences’ Data for Alzheimer’s Disease Clinical Candidate PMN310 Published in Scientific Reports
09/07/2019
Nature Research Journal highlights data supporting the therapeutic potential of PMN310 against the toxic oligomer form of amyloid beta, a root cause of Alzheimer’s disease TORONTO and CAMBRIDGE, Mass., July 09, 2019 ( [...]
Helix BioPharma Corp. Submits L-DOS47 IND Application With U.S. FDA for Pancreatic Cancer
09/07/2019
RICHMOND HILL, Ontario, July 09, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment [...]
Metacrine Doses First Patient in 12-Week NASH Proof-of-Concept Trial with a Sustained FXR Agonist
09/07/2019
Placebo-controlled, multi-center trial will evaluate safety, tolerability and efficacy biomarkers to assess potential best-in-class FXR agonist SAN DIEGO, July 09, 2019 (GLOBE NEWSWIRE) -- Metacrine, Inc., a clinical- [...]
CB2 Insights and Premier Health Group Move to Second Phase of Primary Care Physician Tools for Medical Cannabis Evaluations
09/07/2019
TORONTO, July 09, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIT) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence driven from the point-of-care to the [...]
YSS Corp. Announces Receipt of Five Additional Cannabis Retail Licenses in Alberta, Doubling Currently Licensed Stores to Ten
09/07/2019
CALGARY, Alberta, July 09, 2019 (GLOBE NEWSWIRE) -- YSS Corp.™ (the “ Company ” or “ YSS ”) (TSXV: YSS) (WKN: A2PMAX) is pleased to announce the receipt of five additional cannabis retail licenses from the Alberta [...]
Engage Therapeutics Announces Data from Phase 2a, Proof-of-concept Study of Staccato Alprazolam to Suppress Seizures in Patients with Epilepsy Published in Epilepsia
09/07/2019
– Staccato alprazolam shown to rapidly suppress seizure activity at two minutes in five patients with epilepsy – – Staccato alprazolam generally well tolerated; no serious or severe adverse events reported – – [...]
Cronos Group Appoints Dr. Todd Abraham as Chief Innovation Officer
09/07/2019
36-Year CPG Executive Brings Extensive Experience in Identifying, Developing and Commercializing Breakthrough Technology for Consumer Goods Sector TORONTO, July 09, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: [...]
Clearside Biomedical Announces License Agreement with Aura Biosciences for Suprachoroidal Space Microinjector™ Designed to Optimize Ocular Oncology Drug Delivery
09/07/2019
ALPHARETTA, Ga., July 09, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]
Better Choice Company Appoints Walmart and PepsiCo Veteran Andreas Schulmeyer as Chief Financial Officer
09/07/2019
Schulmeyer Brings Nearly Two Decades of Strategic, Financial and E-Commerce Leadership Experience to Global Animal Health and Wellness CBD Company NEW YORK, July 09, 2019 (GLOBE NEWSWIRE) -- Better Choice Company Inc. ( [...]
Addex-Led Consortium Receives €4.85 Million Eurostars Grant to Develop Novel Allosteric Modulator to Treat Post-Traumatic Stress Disorder (PTSD)
09/07/2019
Geneva, Switzerland, July 9, 2019 – Addex Therapeutics (SIX: ADXN), a leading company pioneering allosteric modulation-based drug discovery and development, today announced that it will lead a consortium for the [...]

Pages